SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpirax-Sarco Regulatory News (SPX)

Share Price Information for Spirax-Sarco (SPX)

Share Price is delayed by 15 minutes
Get Live Data
6,815.00    120.00 (1.79%)
Bid:
6,810.00
Ask:
6,820.00
Spread: 10.00 (0.147%)
Market Cap: £5.03b
SPX Live PriceLast checked at - London Stock Exchange

Intraday Spirax-Sarco Share Chart

Interim Management Statement

9 May 2013 07:00

RNS Number : 2857E
Spirax-Sarco Engineering PLC
09 May 2013
Β 

ο»Ώ

Β 

Β 

News Release

Β 

Thursday 9th May 2013

INTERIM MANAGEMENT STATEMENT

Β 

Spirax-Sarco Engineering plc, the world leader in the control and efficient use of steam and in peristaltic pumping, issues the following Interim Management Statement in respect of the period from 1st January 2013, ahead of its Annual General Meeting ("AGM") today at 2.00pm.

Β 

Trading

Global economic conditions remain broadly unchanged since we reported our 2012 results in early March and trading conditions in most of our markets have been similar to the second half of last year: we continue to see reasonably good base business but restrained customer expenditure for more costly plant improvement and energy saving projects.

Β 

2013 has started in line with our expectations and ahead of last year. For the four months ended 30th April 2013, sales increased by 6%, including a gain of 2% from favourable currency movements as sterling weakened. We achieved growth in all segments, led by good organic sales growth in Asia Pacific followed by Watson-Marlow. We saw modest organic sales growth in Europe, Middle East and Africa ("EMEA"), which was encouraging given the difficult economic background. In the Americas, strong progress in Latin America offset a decline in the US and Canada, where the softness towards the end of 2012 has continued into 2013.

Β 

At constant currency, operating profit and margin were comfortably ahead of the comparable period in 2012 reflecting the contribution from higher sales and, importantly, the further cost savings from the restructuring in Europe, net of increased costs from continued investments in market development. The performance in EMEA was markedly ahead, aided also by favourable currency movements.

Β 

Financial position

Our balance sheet remains very strong and the Group's net cash balance increased from Β£52 million at 31st December 2012 to Β£76 million at 30th April 2013, including Β£5 million due to more favourable exchange rates. If approved at the AGM, the final dividend of 37p per share in respect of 2012, totalling Β£29 million, will be paid on 17th May 2013 and the special dividend of 100p per share, totalling Β£78 million, will be paid on 3rd July 2013. There has been no material change in the financial position of the Group during the period and the principal risks and uncertainties remain as set out on pages 55 to 59 of the 2012 Annual Report.

Β 

Outlook

As noted in previous statements, our markets tend to broadly mirror overall economic activity and industrial production. We anticipate that low rates of industrial production growth will persist this year in most of our mature markets and that conditions in Europe will remain weak but offset by generally higher rates of industrial output in our emerging markets. Our focus is on generating our own growth through our strategic priorities of expanding our presence in emerging markets and driving benefits from the increased investment in R&D in recent years, as well as delivering the full-year cost savings of the European restructuring.

Β 

Our business is seasonally biased to the second half and we are anticipating a more normal first half/second half profile this year. Given the Group's robust business model and fundamental strengths, the Board remains confident that the Group will make further progress in 2013.

Β 

Spirax Sarco will publish its interim results on 8th August 2013.

Β 

Β 

Enquiries:

Mark E Vernon, Chief Executive

David Meredith, Director Finance

Tel: 01242 535234

Β 

Β 

Β 

Β 

About Spirax Sarco

Spirax-Sarco Engineering plc is the world leader in both steam system management and peristaltic pumping. The Company provides a broad range of fluid control products, engineered packages, site services and systems expertise for its diverse range of over 100,000 industrial and institutional customers. The Company helps its customers to optimise production capacity, reduce energy costs and emissions, improve product quality and enhance the safety of their operations. Spirax Sarco is headquartered in Cheltenham, England, has strategically located manufacturing plants around the world and employs approximately 4,700 people, of whom around 1,300 are direct sales and service engineers. Its shares have been listed on the London Stock Exchange since 1959 (symbol: SPX). Further information can be found at www.spiraxsarcoengineering.comΒ 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSBLGDUBGGBGXI
Date   Source Headline
6th Jun 20112:49 pmRNSDirector/PDMR Shareholding
6th Jun 20112:46 pmRNSTotal Voting Rights
27th May 20117:00 amRNSDirectorate Change
12th May 20115:23 pmRNSAGM Statement
10th May 20111:00 pmRNSInterim Management Statement
9th May 20111:38 pmRNSHolding(s) in Company
6th May 20114:25 pmRNSTotal Voting Rights
27th Apr 20119:16 amRNSDirector Declaration
6th Apr 20113:34 pmRNSHolding(s) in Company
1st Apr 20114:50 pmRNSDirector/PDMR Shareholding
1st Apr 20114:48 pmRNSTotal Voting Rights
29th Mar 20115:22 pmRNSDirector/PDMR Shareholding
23rd Mar 20114:48 pmRNSAnnual Financial Report
21st Mar 20113:44 pmRNSDirector/PDMR Shareholding
18th Mar 20114:34 pmRNSDirector/PDMR Shareholding
16th Mar 20114:32 pmRNSDirector/PDMR Shareholding
9th Mar 201110:48 amRNSDirector/PDMR Shareholding
8th Mar 20117:00 amRNS2010 Preliminary Results
1st Mar 20119:28 amRNSTotal Voting Rights
3rd Feb 20115:12 pmRNSHolding(s) in Company
1st Feb 201110:52 amRNSTotal Voting Rights
13th Jan 20114:04 pmRNSNotice of Results
5th Jan 201110:06 amRNSTotal Voting Rights
1st Dec 20104:58 pmRNSTotal Voting Rights
15th Nov 20103:24 pmRNSDirector/PDMR Shareholding
8th Nov 20107:00 amRNSInterim Management Statement
1st Nov 20102:08 pmRNSTotal Voting Rights
28th Oct 201010:53 amRNSDirector Declaration
26th Oct 20108:29 amRNSHolding(s) in Company
26th Oct 20108:29 amRNSHolding(s) in Company
19th Oct 20104:20 pmRNSHolding(s) in Company
12th Oct 201011:06 amRNSAmendment - Director/PDMR Shareholding
11th Oct 20104:43 pmRNSDirector/PDMR Shareholding
1st Oct 20101:13 pmRNSTotal Voting Rights
6th Sep 20104:06 pmRNSDirector/PDMR Shareholding
6th Sep 201010:55 amRNSHolding(s) in Company
2nd Sep 201010:39 amRNSTotal Voting Rights
26th Aug 201011:18 amRNSDirector/PDMR Shareholding
24th Aug 20107:00 amRNS2010 Half Year Results
2nd Aug 20104:26 pmRNSTotal Voting Rights
9th Jul 20109:14 amRNSHolding(s) in Company
7th Jul 201011:59 amRNSAcquisition - Replacement Announcement
7th Jul 201011:32 amRNSAcquisition
7th Jul 20109:55 amRNSHolding(s) in Company
6th Jul 20103:35 pmRNSHolding(s) in Company
6th Jul 20108:44 amRNSHolding(s) in Company
6th Jul 20107:00 amRNSTrading update
1st Jul 201011:15 amRNSTotal Voting Rights
17th Jun 201010:01 amRNSDirector Declaration
15th Jun 20102:48 pmRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.